Preschool children with persistent asthmatic symptoms

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

Abstract

Asthma is the most common chronic airway disease in children, with more than half the reported cases of persistent asthma starting in children below the age of 3 years. Asthma diagnosis in preschool children has proven to be challenging due to the heterogeneity of the disease, the continuing development of the immune system in such a young population, and lack of diagnostic options such as lung function measurement. Early diagnosis and treatment of asthmatic symptoms will improve patients’ quality of life and help reduce disease morbidity. However, validated treatment options are scarce due to paucity of data and lack of conclusive studies in such a young patient population. Adjusting study design and endpoints to capture more reliable data with minimal risk of harm to patients is necessary. This thematic series review outlines the current position on preschool asthma, consolidates the current understanding of risk factors and diagnostic hurdles, and emphasizes the importance of early detection and management to help improve patients’ quality of life, both present and future. Particular focus was given to anticholinergics and their emerging role in the treatment and control of asthma in pediatric patients.

Details

Original languageEnglish
Pages (from-to)451-460
Number of pages10
JournalTherapeutics and clinical risk management
Volume15
Publication statusPublished - 2019
Peer-reviewedYes

Keywords

Keywords

  • Anticholinergic, Asthmatic symptoms, Preschool children, Tiotropium